Skip to main content

 Related scientific articles (all)

Combined quality and dose-volume histograms for assessing the predictive value of <sup>99m</sup>Tc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer.

Authors : Levillain H, Burghelea M, Derijckere ID, Guiot T, Gulyban A, Vanderlinden B, Vouche M, Flamen P, Reynaert N
Year : 2020
Journal : EJNMMI Phys
Volume : 7
Pages : 75

NIR Infrared imaging after peritumoral injection of indocyanine green to guide lymph node dissection in head and neck squamous cell carcinoma: A pilot feasibility study.

Authors : Digonnet A, Barbieux R, Moreau M, Dekeyser C, Quiriny M, Willemse E, de Saint-Aubain de Somerhausen N, Cappello M, Donckier V, Bourgeois P
Year : 2020
Journal : Oral Oncol
Volume : 104
Pages : 104621

How COVID-19 pandemic affected cancer progression: Three different scenarios evidenced by PET imaging.

Authors : Mileva M, Artigas C, Gebhart G, Flamen P, Karfis I
Year : 2020
Journal : Hell J Nucl Med
Volume : 23
Pages : 349-353

Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy.

Authors : Craciun L, de Wind R, Demetter P, Willard-Gallo K, Lucidi V, Bohlok A, Michiels S, Bouazza F, Vouche M, Tancredi I, Verset G, Garaud S, Naveaux C, Gomez Galdon M, Hendlisz A, Derijckere ID, Flamen P, Larsimont D, Donckier V
Year : 2020
Journal : BMC Cancer
Volume : 20
Pages : 135

Prognostic value of a three-scale grading system based on combining molecular imaging with <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias.

Authors : Karfis I, Marin G, Levillain H, Drisis S, Muteganya R, Critchi G, Taraji-Schiltz L, Guix CA, Shaza L, Elbachiri M, Mans L, Machiels G, Hendlisz A, Flamen P
Year : 2020
Journal : Oncotarget
Volume : 11
Pages : 589-599

Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer.

Authors : Hunter FW, Barker HR, Lipert B, Rothé F, Gebhart G, Piccart-Gebhart M, Sotiriou C, Jamieson SMF
Year : 2020
Journal : Br J Cancer
Volume : 122
Pages : 603-612

Added value of para-aortic surgical staging compared to <sup>18</sup>F-FDG PET/CT on the external beam radiation field for patients with locally advanced cervical cancer: An ONCO-GF study.

Authors : De Cuypere M, Lovinfosse P, Goffin F, Gennigens C, Rovira R, Duch J, Fastrez M, Gebhart G, Squifflet JL, Luyckx M, Charaf G, Crener K, Buxant F, Bucella D, Jouret M, Hustinx R, Kridelka F
Year : 2020
Journal : Eur J Surg Oncol
Volume : 46
Pages : 883-887

Early prediction of neoadjuvant treatment outcome in locally advanced breast cancer using parametric response mapping and radial heterogeneity from breast MRI.

Authors : Drisis S, El Adoui M, Flamen P, Benjelloun M, de Wind R, Paesmans M, Ignatiadis M, Bali MA, Lemort M
Year : 2020
Journal : J Magn Reson Imaging
Volume : 51
Pages : 1403-1411

The metabolic clinical risk score as a new prognostic model for surgical decision-making in patients with colorectal liver metastases.

Authors : Duran Derijckere I, Levillain H, Bohlok A, Mathey C, Nezri J, Muteganya R, Trotta N, Lucidi V, Bouazza F, Germanova D, Van Simaeys G, Goldman S, Hendlisz A, Flamen P, Donckier V
Year : 2019
Journal : J Surg Oncol

Advanced Stage at Diagnosis and Worse Clinicopathologic Features in Young Women with Breast Cancer in Brazil: A Subanalysis of the AMAZONA III Study (GBECAM 0115).

Authors : Franzoi MA, Rosa DD, Zaffaroni F, Werutsky G, Simon S, Bines J, Barrios C, Cronemberger E, Queiroz GS, Cordeiro de Lima V, Júnior RF, Couto J, Emerenciano K, Resende H, Crocamo S, Reinert T, Van Eyli B, Nerón Y, Dybal V, Lazaretti N, de Cassia Costamillan R, Pinto de Andrade DA, Mathias C, Vacaro GZ, Borges G, Morelle A, Filho CAS, Mano M, Liedke PER
Year : 2019
Journal : J Glob Oncol
Volume : 5
Pages : 1-10

Evaluation of PSMA expression changes on PET/CT before and after initiation of novel antiandrogen drugs (enzalutamide or abiraterone) in metastatic castration-resistant prostate cancer patients.

Authors : Plouznikoff N, Artigas C, Sideris S, Martinez Chanza N, Gil T, Peltier A, Flamen P
Year : 2019
Journal : Ann Nucl Med
Volume : 33
Pages : 945-954

Scintigraphic Investigations of the Deep and Superficial Lymphatic Systems in the Evaluation of Lower Limb Oedema.

Authors : Barbieux R, Roman M, Rivière F, Leduc O, Leduc A, Bourgeois P, Provyn S
Year : 2019
Journal : Sci Rep
Volume : 9
Pages : 13691

The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma.

Authors : Krayem M, Sabbah M, Najem A, Wouters A, Lardon F, Simon S, Sales F, Journe F, Awada A, Ghanem G, Van Gestel D
Year : 2019
Journal : Cancers (Basel)
Volume : 11

Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study.

Authors : Levillain H, Duran Derijckere I, Ameye L, Guiot T, Braat A, Meyer C, Vanderlinden B, Reynaert N, Hendlisz A, Lam M, Deroose CM, Ahmadzadehfar H, Flamen P
Year : 2019
Journal : Eur J Nucl Med Mol Imaging
Volume : 46
Pages : 2270-2279

First case of <i>Campylobacter rectus</i> and <i>Solobacterium moorei</i> mixed bacteraemia successfully identified by MALDI TOF-MS.

Authors : Genderini FG, Martiny D, Ponthieux F, Argudín MA, Gomez Galdon M, Zaarour A, Garcia C, Libois A, Gérard M, Dauby N
Year : 2019
Journal : New Microbes New Infect
Volume : 31
Pages : 100587

Incidental Detection of a Radiation-Induced Soft-Tissue Sarcoma on 68Ga-PSMA PET/CT in a Patient Previously Treated for Prostate Cancer.

Authors : Plouznikoff N, Woff E, Artigas C, Alexiou J, Flamen P
Year : 2019
Journal : Clin Nucl Med
Volume : 44
Pages : e501-e502

68Ga-PSMA-11 PET/CT in a patient with non-PSA-secreting undifferentiated prostate cancer before and after treatment with cabozantinib.

Authors : Artigas C, Plouznikoff N, Gil T, Duran Derijckere I, Herchuelz M, Libert I, Flamen P
Year : 2019
Journal : Eur J Nucl Med Mol Imaging
Volume : 46
Pages : 1978-1979

Heterogeneity of 68Ga-PSMA PET/CT Uptake in Fibrous Dysplasia.

Authors : Plouznikoff N, Garcia C, Artigas C, Entezari K, Flamen P
Year : 2019
Journal : Clin Nucl Med
Volume : 44
Pages : e593-e594

Combining 18F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer.

Authors : Woff E, Kehagias P, Vandeputte C, Ameye L, Guiot T, Paesmans M, Hendlisz A, Flamen P
Year : 2019
Journal : J Nucl Med
Volume : 60
Pages : 1366-1372

68Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy.

Authors : Artigas C, Flamen P, Charlier F, Levillain H, Wimana Z, Diamand R, Albisinni S, Gil T, Velthoven Rv, Peltier A, Van Gestel D, Roumeguere T, Otte FX
Year : 2019
Journal : World J Urol
Volume : 37
Pages : 1535-1542